Episode

AliveAndKickn Podcast - Dr Mev Dominguez

Podcast
AliveandKick'n the podcast
Published
Feb 10, 2026
Duration seconds
2407
Processing state
not_requested
Canonical source
https://aliveandkickn.libsyn.com/aliveandkickn-podcast-dr-mev-dominguez
Audio
https://traffic.libsyn.com/secure/aliveandkickn/DrMevDominguez.mp3?dest-id=1596059
JSON
/v1/public/podcasts/aliveandkick-n-the-podcast-1330226/episodes/aliveandkickn-podcast-dr-mev-dominguez
Markdown
/podcast/aliveandkick-n-the-podcast-1330226/aliveandkickn-podcast-dr-mev-dominguez.md

Actions

  • POST https://stenobird.com/v1/public/podcasts/aliveandkick-n-the-podcast-1330226/episodes/aliveandkickn-podcast-dr-mev-dominguez/transcription-requests
    Idempotently request low-priority transcript generation for this episode.
  • GET https://stenobird.com/podcast/aliveandkick-n-the-podcast-1330226/aliveandkickn-podcast-dr-mev-dominguez.md
    Read the agent-friendly Markdown representation of this episode resource.

Summary

I sit down with Dr Mev Dominguez, Project Group Leader Inherited and Familial Cancer at the University of Oslo and Director of the Predi Lynch Project. Starting in May 2025, lasting for 6 years, there are 28 partners from 16 European countries acting and working together. Liquid biopsy every year, urine, MSI plus, vaginal swabs, and stool samples will be compiled over 27 clinical centers. Important factors include social and financial acceptability. Open for lynch syndrome patients over age 35 but no cancer for the last year. A biobank will be created, and analysis will be done using AI. Everything should be followed via the Predi-lynch.edu web site.